Acetylsalicylic acid 100 mg and 1000 mg daily in acute myocardial infarction suspects: a placebo‐controlled trial
暂无分享,去创建一个
[1] B. Rabinowitz,et al. [Aspirin in coronary heart disease]. , 1989, Harefuah.
[2] T. Galema,et al. Low dose aspirin after early thrombolysis in anterior wall acute myocardial infarction. , 1988, The American journal of cardiology.
[3] R. Doll,et al. Randomised trial of prophylactic daily aspirin in British male doctors , 1988, British medical journal.
[4] K. McPherson,et al. Secondary prevention of vascular disease by prolonged antiplatelet treatment , 1988, British medical journal.
[5] Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study. , 1988, The New England journal of medicine.
[6] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. LONG-TERM EFFECTS OF INTRAVENOUS THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION: FINAL REPORT OF THE GISSI STUDY , 1987, The Lancet.
[7] K. Wegscheider,et al. Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) Study. , 1987, Circulation.
[8] R M Whitlock,et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.
[9] S. Sherry. Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction? , 1987, The American journal of cardiology.
[10] R. Kloner,et al. Analysis of reported randomized trials of streptokinase therapy for acute myocardial infarction in the 1980s. , 1987, The American journal of cardiology.
[11] J. Haft,et al. Is coronary arterial spasm part of the aspirin-induced asthma syndrome? , 1986, Chest.
[12] J. Stamler,et al. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin. , 1986, Journal of the American College of Cardiology.
[13] D. Sackett,et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.
[14] M. Stampfer,et al. Cumulative antiplatelet effect of low‐dose enteric coated aspirin , 1985, British journal of haematology.
[15] E. Falk. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.
[16] D. Rifkin,et al. Aspirin inhibits vascular plasminogen activator activity in vivo. Studies utilizing a new assay to quantify plasminogen activator activity. , 1984, The Journal of clinical investigation.
[17] P. Weber,et al. IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY) Effects on Platelet Aggregation and Thromboxane Formation , 1984, The Lancet.
[18] Niels Jørgen Christensen,et al. A new automated technique for platelet aggregation measurement. , 1984, Scandinavian Journal of Clinical and Laboratory Investigation.
[19] R M Centor,et al. Inability to predict relapse in acute asthma. , 1984, The New England journal of medicine.
[20] M. LeWinter,et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.
[21] G. FitzGerald,et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. , 1983, The Journal of clinical investigation.
[22] C. Patrono,et al. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. , 1982, The Journal of clinical investigation.
[23] P. Elwood. Trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. , 1981, British medical journal.
[24] Lippincott Williams Wilkins,et al. Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group. , 1980, Circulation.
[25] J. Knudsen,et al. Changes in Platelet Functions, Coagulation and Fibrinolysis in Uncomplicated Cases of Acute Myocardial Infarction , 1979, Thrombosis and Haemostasis.
[26] A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. , 1980, JAMA.
[27] P. Elwood,et al. ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION , 1979, The Lancet.
[28] P. Majerus,et al. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. , 1979, The New England journal of medicine.
[29] K Uberla,et al. Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo , 1979, Thrombosis and Haemostasis.
[30] P C Elwood,et al. A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction , 1974, British medical journal.